[{"Assets_0_Q3_USD":37893100000.0,"EarningsPerShareDiluted_1_Q3_USD":1.37,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":938200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":913900000.0,"EarningsPerShareBasic_3_Q3_USD":7.27,"EarningsPerShareBasic_1_Q3_USD":1.37,"StockholdersEquityConverted_0_Q3_USD":3462300000.0,"EarningsPerShareDiluted_3_Q3_USD":7.24,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":942400000.0,"StockholdersEquity_0_Q3_USD":3382500000.0,"RevenuesConverted_1_Q3_USD":5476600000.0,"RevenuesConverted_3_Q3_USD":16205500000.0,"NetIncomeLossConverted_1_Q3_USD":1253900000.0,"NetIncomeLossConverted_3_Q3_USD":6822700000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":2872900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":918500000.0,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.29,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20191025"}]